טוען...
The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds
BACKGROUND: Sutherlandia frutescens (L.) R. Br is endemic to Southern Africa where it has been traditionally used for cancer and diabetes. In recent times it has been marketed for its reputed (but not proven) anticancer, antidiabetic and anti-HIV properties. Little is known about the mutagenic and a...
שמור ב:
| הוצא לאור ב: | BMC Complement Altern Med |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856389/ https://ncbi.nlm.nih.gov/pubmed/29544492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-018-2159-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|